GSK break-up? Don't bank on it, says drugmaker's outgoing boss
0
LONDON (Reuters) - News that GlaxoSmithKline will have a new chief executive in 12 months has fueled speculation about a break-up of Britain's biggest drugmaker but outgoing boss Andrew Witty says this is wide of the mark.